Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $24 By Benzinga Newsdesk July 14, 7:51 AM Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $20 to $24. AHCO